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patients requiring intermediate care: a
national cohort study using linked
databases
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Abstract
Background: Adults increasingly live and die with chronic progressive conditions into advanced age. Many live
with multimorbidity and an uncertain illness trajectory with points of marked decline, loss of function and increased
risk of end of life. Intermediate care units support mainly older adults in transition between hospital and home to
regain function and anticipate and plan for end of life. This study examined the patient characteristics and the
factors associated with mortality over 1 year post-admission to an intermediate care unit to inform priorities for
care.
Methods: A national cohort study of adults admitted to intermediate care units in England using linked individual-
level Hospital Episode Statistics and death registration data. The main outcome was mortality within 1 year from
admission. The cohort was examined as two groups with significant differences in mortality between main
diagnosis of a non-cancer condition and cancer. Data analysis used Kaplan-Meier curves to explore mortality
differences between the groups and a time-dependant Cox proportional hazards model to determine mortality risk
factors.
Results: The cohort comprised 76,704 adults with median age 81 years (IQR 70–88) admitted to 220 intermediate
care units over 1 year in 2016. Overall, 28.0% died within 1 year post-admission. Mortality varied by the main
diagnosis of cancer (total n = 3680, 70.8% died) and non-cancer condition (total n = 73,024, 25.8% died). Illness-
related factors had the highest adjusted hazard ratios [aHRs]. At 0–28 days post-admission, risks were highest for
non-cancer respiratory conditions (pneumonia (aHR 6.17 [95%CI 4.90–7.76]), chronic obstructive pulmonary disease
(aHR 5.01 [95% CI 3.78–6.62]), dementia (aHR 5.07 [95% CI 3.80–6.77]) and liver disease (aHR 9.75 [95% CI 6.50–14.6])
compared with musculoskeletal disorders. In cancer, lung cancer showed largest risk (aHR 1.20 [95%CI 1.04–1.39])
compared with cancer ‘other’. Risks increased with high multimorbidity for non-cancer (aHR 2.57 [95% CI 2.36–2.79])
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and cancer (aHR 2.59 [95% CI 2.13–3.15]) (reference: lowest).
Conclusions: One in four patients died within 1 year. Indicators for palliative care assessment are respiratory
conditions, dementia, liver disease, cancer and rising multimorbidity. The traditional emphasis on rehabilitation and
recovery in intermediate care units has changed with an ageing population and the need for greater integration of
palliative care.
Keywords: Intermediate care facilities, Health services for the aged, Subacute care, Geriatrics, Palliative care,
Mortality, Cohort studies
Background
Adults increasingly live and die with chronic pro-
gressive conditions into advanced age. The Lancet
Commission in 2017 identified living with chronic ill-
ness that compromises physical, social or emotional
function as a construct of serious health-related suf-
fering relieved by palliative care where quality of life
is the main goal of care [1]. Globally, the greatest
increase in serious health-related suffering is pro-
jected for people aged 70 years and over [2]. Living
into advanced age is often accompanied by multi-
morbidity and frailty and an uncertain illness trajec-
tory of gradual decline over many years into end of
life [3–5]. This trajectory is punctuated by points of
marked decline from an often seemingly minor
event, like an infection and risk of poor outcomes
including hospitalisation and death [4]. Unplanned
hospitalisations are common and rise with nearness
of end of life [6, 7]. This trajectory is well described,
but less understood are the priorities for high-quality
care for people to live as well as possible with
advancing age and chronic conditions [5].
Inpatient intermediate care units, such as a community
hospital or post-acute facility, are an important part of
the continuum of care to manage the care needs for
people with chronic progressive conditions. They care
increasingly for a mainly older population to provide
time-limited transitional care between different levels of
care and settings, for example, acute hospital and home.
Care focuses on supporting recovery and function
following points of decline with emphasis on compre-
hensive geriatric assessment, enablement and rehabilita-
tion [8, 9]. These units are generally small (≤ 30 beds)
[10] and provide subacute services tailored to the needs
of the local population with varying access to specialist ser-
vices such as a geriatrician, alongside the core staff [8, 9].
Patients and family carers describe these facilities positively
placing particular value on location close to home that
enables holistic and personalised care facilitated by multi-
disciplinary team working and support for difficult psycho-
logical transitions, for example, loss of independence with
disease progression [10]. Systematic review evidence
demonstrates that compared with acute hospital care,
patients and family carers in intermediate care units report
better experiences and care is cost-effective to support
post-acute recovery and rehabilitation [8, 11]. However, less
considered is risk of end of life and the need for care orien-
tated towards quality of life and comprehensive palliative
care assessment.
Orientating services to changing population needs and
identifying priorities to ensure high-quality care is best
informed by understanding care needs at a population-
level. However, there is a dearth of population-based evi-
dence on the characteristics of adults admitted to inter-
mediate care units and nearness of death and the
associated factors. Our review of evidence before this
study on mortality over 1 year post-admission to an
intermediate care unit (community hospital, post-acute
care or skilled nursing facility) identified twelve studies
[12–23] reporting approximately 661,751 participants
(Additional file D: Tables D1-D2). No studies considered
the total population at the national level or indicators
for care where quality of life is the main goal. Rather,
the studies reported discrete populations by a specific
disease(s), intervention or region to identify factors asso-
ciated with mortality, for example, physical function and
quality of care. This study aimed to examine the patient
cohort characteristics and factors associated with mor-
tality over 1 year post-admission to an intermediate care
unit in England. The findings intended to inform policy
and clinical priorities to deliver high-quality care for
people in transition between hospital and home and
requiring intermediate care.
Methods
Study design, data sources and participants
A national retrospective cohort study using linked data-
bases. These included National Health Service (NHS)
Hospital Episode Statistics (HES) linked at the
individual-level to the Office for National Statistics
(ONS) death registration data. Intermediate care units
were defined in the HES data as a community hospital
with inpatient beds in England. Data were extracted for
all adults admitted to an intermediate care unit, 01/01/
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2016 to 31/12/2016 as the most complete datasets. NHS
Digital supplied the HES data and ONS death registra-
tion records data linked by an individual anonymised
identifier to enable deterministic linkage [24]. HES data
details information about all patients admitted to NHS
hospitals in England [25]. It captures illnesses and
related conditions, with each electronic record contain-
ing up to 20 diagnosis fields coded according to Inter-
national Classification of Diseases, 10th edition (ICD-10)
[26]. The population cohort included adults (≥ 18 years)
admitted for ≥ 1 nights to an eligible intermediate care
unit between 01/01/2016 and 31/12/2016, with 12-month
follow-up until end of 2017. Individuals were excluded
using outpatient (e.g. day case) or maternity facilities.
Reporting follows the STROBE guideline [27] and the REC-
ORD [28] extension for routine data (Additional file A:
Table A1).
Procedures
The vital status (alive or dead) of the cohort was identi-
fied from the linked mortality data for date of death over
the 12 months from the first admission (the index
admission) to an intermediate care unit. Patients where
a linked death record was not identified were assumed
to have survived. HES data on hospital admission were
aggregated into a patient “spell” in a single hospital. Each
spell encompassed all episodes of care reported in the
identified intermediate care unit to confirm the admis-
sion and discharge dates. Discharge included to usual
residence, transfer to another medical facility or death.
All intermediate care units in England in the HES data
were reviewed to identify those with inpatient facilities
and reported admissions of ≥ 1 night in 2016. But identi-
fying the facilities was convoluted. These facilities are
not automatically differentiated in the HES database.
Initially, facilities were identified from the names and
postcodes from the Community Hospital Association
(CHA), UK database [29] and each postcode checked
with the respective facility website. Each confirmed post-
code was mapped to the NHS site code in the NHS
Trust Site database [30] and each site code then checked
in the NHS successor archive database [31] to remove
facilities that closed in 2016.
Main outcome and covariates
The main outcome was mortality within 1 year from the
index admission. The last year of life is considered a key
indicator for likely benefit from palliative care [32]. The
covariates examined as associated with end of life
included demographic, illness and environmental factors.
Demographic covariates included age (grouped for clin-
ical relevance), sex and ethnicity. Illness factors were the
main diagnosis derived from the first recorded diagnosis
code on the index admission. Codes were recorded in
ICD-10 and grouped using respective chapter codes
(Additional File C: Tables C4-C5). Comorbidities were
calculated from the Charlson comorbidity index for each
person using the R ‘comorbidity’ package (version
0.5.3.9) [33, 34]. All recorded diagnoses were collated
from the index admission and hospital episodes over
1 year before the index admission [35]. Environment
covariates included the admission setting (e.g. post-
acute), admission type categorised as elective when the
decision to treat was prescribed before the admission, or
non-elective, and level of deprivation by usual place of
residence using index of multiple deprivation indices
[36] at Lower Super Output Area (LSOA).
Statistical analysis
Patient socio-demographics and clinical characteristics
were described with descriptive statistics. Kaplan-Meier
curves were used to visualise survival probabilities by
respective explanatory variables. The multivariate sur-
vival analysis used a time-dependant Cox proportional
hazards (PH) model to determine factors associated with
mortality. All descriptive socio-demographic and clinical
variables (see Table 1) were examined for inclusion in
the survival model. The model included only complete
cases for the identified covariates.
The modelling procedure for the multivariate analysis
was as follows. First, data were split into two cohorts, of
main diagnosis non-cancer condition or cancer at the
index admission. Sensitivity analysis showed that the
survival profile for a main diagnosis of a non-cancer
condition was significantly different from cancer. Indi-
viduals with a main diagnosis of a non-cancer condition
may have had a history of cancer, but this was not
reported as the reason for admission. Two separate
models were fitted to accommodate the difference in
mortality between the non-cancer and cancer groups.
Initially, a stepwise variable selection procedure obtained
the best Cox PH model for each cohort, using bidirec-
tional selection with p value entry criterion 0.1 and
retention criterion of 0.05 (Additional file B). The
models were selected that had the maximum concord-
ance statistic (a measure of goodness of fit) and con-
tained the fewest covariates, retaining those with clinical
importance (e.g. admission type). The Schoenfeld resid-
uals of each covariate were tested for proportional
hazards. However, the non-proportional hazards violated
the assumptions of the Cox PH approach. To address
this, time-dependant coefficients were used for covari-
ates that had a non-stationary effect on mortality over-
time (e.g. main diagnosis) [37]. This meant that
coefficients for covariates that violated the proportional
hazards assumption could vary as a step function over-
time [37]. Time intervals of 28 days in the cancer model
and 28 days and 180 days in the non-cancer model were
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Table 1 Demographics of the study population
Non-cancer Cancer All
Total number of patients 73,024 3680 76,704
Mortality 365 days from admission 18,840 (25.8%) 2605 (70.8%) 21,477 (28.0%)
Days until death from admission
0–28 nights 3615 (19.2%) 1433 (55.0%) 5048 (23.5%)
29–180 nights 9587 (50.8%) 964 (37.0%) 10,551 (49.2%)
181–365 nights 5657 (30.0%) 209 (8.0%) 5866 (27.3%)
Age (years)
Mean (SD) 76.8 (15.9) 73.9 (12.8) 76.7 (15.8)
Median (IQR) 81 (71–88) 76 (67–83) 81 (70–88)
Age (years)
18–39 3226 (4.4%) 60 (1.6%) 3286 (4.3%)
40–64 9103 (12.5%) 685 (18.6%) 9788 (12.8%)
65–74 10,927 (15.0%) 976 (26.5%) 11,903 (15.5%)
75–84 21,848 (29.9%) 1194 (32.5%) 23,042 (30.0%)
85–94 24,657 (33.8%) 713 (19.4%) 25,370 (33.1%)
95+ 3263 (4.5%) 52 (1.4%) 3315 (4.3%)
Sex
Female 43,228 (59.2%) 1932 (52.5%) 45,100 (58.8%)
Male 29,793 (40.8%) 1748 (47.5%) 31,601 (41.2%)
Ethnicity
White 69,892 (95.7%) 3574 (97.1%) 73,466 (95.8%)
Black and ethnic minority 1930 (2.6%) 41 (1.1%) 1971 (2.6%)
Unknown 1202 (1.7%) 65 (1.8%) 1267 (1.7%)
Charlson comorbidity index
Median (IQR) 1 (0–3) 8 (3–9) 2 (0–3)
Range 0–18 2–17 0–18
Charlson comorbidity index
0 20,155 (27.6%) 0 (0.0%) 20,155 (26.3%)
1–2 28,386 (38.9%) 713 (19.4%) 29,099 (37.9%)
3–4 15,275 (20.9%) 667 (18.1%) 15,942 (20.8%)
≥ 5 9208 (12.6%) 2300 (62.5%) 11,508 (15.0%)
Admission type
Elective 16,535 (22.7%) 1257 (34.2%) 17,828 (23.3%)
Non-elective 56,307 (77.3%) 2418 (65.8%) 58,689 (76.7%)
Admitted from
Hospital (ED or general hospital) 33,553 (46.0%) 1360 (37.0%) 34,913 (45.5%)
Home (personal dwelling/care home) 36,585 (50.1%) 2286 (62.1%) 38,871 (50.7%)
Other 617 (0.8%) 15 (0.4%) 632 (0.8%)
Unknown 2269 (3.1%) 19 (0.5%) 2288 (3.0%)
Length of stay in an intermediate care unit
Median (IQR) 17 (5–34) 8 (5–34) 17 (5–34)
Range 0–1073 0–190 0–1073
Length of stay in an intermediate care unit
0–25 nights 46,916 (64.6%) 2961 (80.6%) 49,877 (65.4%)
26+ nights 25,733 (35.4%) 712 (19.4%) 26,445 (34.7%)
Data are n (%) and represent status at index admission to the intermediate care unit. Charlson Index includes all malignancy, including lymphoma and leukaemia,
except malignant neoplasm of skin [35]. Abbreviations: SD standard deviation, IQR interquartile range, ED emergency department. Definition: home and
community setting, e.g. own home, care home (with or without nursing) but not residential accommodation where medical care is provided, e.g.
inpatient hospice
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identified by depicting the original hazard estimate
against the time-varying estimate of a given covariate.
The final model fit was assessed by visually comparing
observed to expected hazard plots and observing con-
cordance statistics. All analyses were completed in R
(version 3.6.1). All statistical tests were 2-sided at a level
of p ≤ 0.05.
Research ethics statement
The study used anonymous national datasets. ONS
Individual Approvals for full data access were held by
LP, UD and AP. CJE and WG accessed the aggre-
gated data. Ethical approval was not required.
Results
Study population
From 01/01/2016 to 31/12/2016, 76,704 individual adults
were admitted to 220 intermediate care units in England
(Fig. 1). The facilities were in both urban and rural local-
ities. Most facilities had a single ward (71%) providing
general medical care (Additional file C: Tables C2-C3).
We identified 266 intermediate care units but excluded
46 (17.3%) with no admissions recorded, because of, for
example, closure of inpatient beds.
Table 1 shows the characteristics of the cohort. Most
patients were older with a median age at admission of
81 years (IQR 70–88, range 18–107), ethnically white
(95.8%) and female (58.8%). The population formed two
overarching groups identified by the main admission
diagnosis of cancer (n = 3680, 4.8%) or non-cancer con-
dition (n = 73,024, 95.2%) with significant difference in
mortality (70.8% vs. 25.8% respectively). The main can-
cer site were digestive organs (23.6%) (Additional file C:
Tables C1, C4-C5). The non-cancer conditions were
highly heterogeneous with prominent conditions of in-
juries (17.0%) and ‘unknown and unspecified causes of
morbidity’ (12.7%) (Additional file C: Table C1, C4-C5).
Multimorbidity was common (73.7%) and highest in the
cancer group (62.5% highest score of ≥ 5). Admission
were non-elective (total n = 58,689, 76.7%) from hospital
(45.5%) or usual residence (50.7%).
Main outcome
Mortality over 1 year varied by diagnosis (cancer 2605,
70.8%), and non-cancer (18,840, 25.8% cases died) (see
Fig. 2a). Deaths in the cancer group largely occurred 0
to 28 days post-admission (1433, 55.0%), and in the non-
cancer group 29 to 180 days post-admission (9587,
50.8%) (Fig. 2a, Table 1). In the non-cancer group,
chronic heart disease, respiratory diseases (pneumonia
and chronic obstructive pulmonary disease [COPD]),
dementia and liver disease had lowest survival probabil-
ity over time (see Fig. 2b). Increasing comorbidities
showed declining survival probability in both the cancer
and non-cancer groups (see Fig. 2c). In both groups, the
index admission was mainly non-elective (non-cancer
56,307, 77.3%; cancer 2418, 65.8% cases), with similar
proportions admitted post-acute (non-cancer 33,553,
46.0%; cancer 1360, 37.0%) or usual residence (non-can-
cer 36,585, 50.1%; cancer 2286, 62.1%). Survival
increased with decreasing age in both groups (Additional
file C: Fig.C1, Kaplan-Meir curve by age categories).
The multivariate analysis used two models of non-
cancer (72839) and cancer (3675), total 76,514 complete
cases. Tables 2 and 3 show the respective model and the
factors associated with mortality. The models included
six covariates comprising age, sex, comorbidities
(Charlson index score), main diagnosis, admission type
and admission setting. To meet the hazards assumption
of variation by time, step functions were employed at 28
days and 29–365 days in the cancer model, and 0–28
days, 29–180 and 181–365 days in the non-cancer
model.
In the non-cancer model, typically all covariates
remained significant overtime compared to the respect-
ive reference covariate (Table 2). The model showed a
good fit with high concordance at 0.725. Females
showed a consistently lower hazard ratio relative to
males men (0 to 28 days aHR 0.80 [95% CI, 0.75–0.85]),
and elective compared to non-elective admissions (0 to
28 days aHR 0.81 [95% CI 0.73–0.90]). Admissions from
hospital showed the highest risk of mortality at 0 to 28
days (aHR 1.26 [95% CI 1.18–1.35]) compared with from
usual residence (e.g. home). Hazard ratios increased with
increasing comorbidities (Charlson Index) and age and
remained consistent overtime. Conversely, the hazard
ratios for main diagnosis on index admission were
generally highest in the 0 to 28 days post-admission, and
decreased overtime. Prominent conditions relative to
MSK disorders comprised pneumonia (aHR 6.17 [95%
CI 4.90–7.76]), chronic heart disease (adjusted HR 6.14
[95% CI 4.83–7.81]), dementia (aHR 5.07 [95% CI 3.80–
6.77]), COPD (aHR 5.01 [95% CI 3.78–6.62]), renal and
genitourinary (aHR 3.05 [95% CI 2.41–3.87]) and
cerebrovascular disease (aHR 3.02 [95% CI 2.35–3.88]).
The six covariates in the cancer model showed greater
variation overtime and slightly lower model concordance
of 0.686 compared to the non-cancer model (Table 3).
The cancer model showed that patients admitted post-
acute had a lower hazard ratio compared with those
transferring from usual residence (0 to 28 days aHR 0.85
[95% CI 0.77–0.95] and 29 to 365 days aHR 0.86 [95%
CI 0.76–0.98]). Of those admitted from home, 58.9%
had a Charlson index of ≥ 3 compared to 40.3% admitted
from hospital. Patients with increasing comorbidities
(Charlson index ≥ 5) showed the largest ratio (aHR 2.59
[95% CI 2.13–3.15] 0–28 days) relative to the lowest
index (1–2). Hazard ratios varied by cancer type with
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lung cancer showing highest ratio (aHR 1.20 [95% CI
1.04–1.39] 0 to 28 days) relative to ‘other’ cancer condi-
tions. Mortality increased with rising age, but a pattern




This study reports a novel analysis of the characteristics
of a national cohort of adults admitted to intermediate
care units and outcome of death over 1 year. The find-
ings show that this is a mainly older population with
chronic progressive disease and multimorbidity. Over
one in four were in the last year of life. The wide vari-
ation in end of life indicates the need for care and treat-
ment to support both recovery and plan for and
anticipate end of life. The findings on the associations
with end of life identify triggers for palliative care in-
cluding the main diagnosis (respiratory conditions, de-
mentia, liver disease and cancer), high multimorbidity
(≥ 5 Charlson index score), advanced age and non-
elective admission. This is a population with high care
needs including management of multiple progressive
conditions, supporting recovering and anticipating and
planning for end of life. The findings challenge percep-
tions of intermediate care settings, with relatively low
technology, as managing seemingly simplistic care needs.
New models of care are indicated with better integration
between intermediate care facilities, geriatric care and
palliative care, and a skilled workforce to manage mul-
tiple care needs across the continuum of care and into
end of life.
We compared our findings on associations with end of
life with 12 studies included in our systematic review on
Fig. 1 Study cohort profile
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Fig. 2 Kaplan-Meier survival curves and 95% confidence intervals by a main admission reason relating to cancer and non-cancer, b main
diagnosis and c Charlson comorbidity index by cancer and non-cancer
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Table 2 Non-cancer model and factors associated with mortality within 1 year post-admission (complete cases n = 72,839)
Covariate [*denotes
reference group]
0 to 365 days Hazard up to 28 daysa Hazard 29 to 180 daysb Hazard 181 to 365 daysc
n/N (%) n/N (%) Adjusted hazard
ratio (95% CI)
n/N (%) Adjusted hazard
ratio (95% CI)







0.38 (0.32, 0.44) 313/12,097
(3%)







0.58 (0.52, 0.65) 906/10,487
(9%)







0.7 (0.65, 0.75) 2852/20,695
(14%)


























0.8 (0.75, 0.85) 5095/41,259
(12%)








0.59 (0.52, 0.67) 1050/19,747
(5%)
















1.39 (1.28, 1.52) 2737/14,259
(19%)







2.57 (2.36, 2.79) 2386/8061
(30%)

















0.81 (0.73, 0.90) 1081/16,128
(7%)



















1.26 (1.18, 1.35) 4987/31,437
(16%)
0.97 (0.93, 1.01) 3036/26,450
(11%)
1.07 (1.02, 1.13)




0.74 (0.60, 0.91) 351/2771
(13%)
0.83 (0.75, 0.93) 245/2420
(10%)
1.02 (0.89, 1.16)














1.38 (1.09, 1.74) 1495/12,703
(12%)









3.05 (2.41, 3.87) 783/4563
(17%)









3.02 (2.35, 3.88) 375/2876
(13%)
1.36 (1.19, 1.57) 203/2501
(8%)
1.12 (0.94, 1.35)




3.47 (2.67, 4.51) 306/2695
(11%)







6.17 (4.90, 7.76) 553/2480
(22%)
2.31 (2.03, 2.62) 329/1927
(17%)
2.34 (2.00, 2.74)




6.14 (4.83, 7.81) 399/1577
(25%)
2.41 (2.10, 2.76) 182/1178
(15%)
1.89 (1.57, 2.28)
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evidence before the study (Additional file D: Table D1).
We extracted the relative risk estimates for the factors
associated with mortality reported in 11 studies with es-
timates from our study presented alongside (Additional
file D: Table D2). The synthesis of the relative risk data
informs factors associated with increasing risk of end of
life encompassing demographic, illness and environmen-
tal factors. Our study was unique to identify the main
diagnosis as a key factor for risk of end of life. These
‘triggers’ against a background of multimorbidity and
frailty can precipitate marked functional decline and risk
of adverse outcome of, for example, death [4]. However,
the review findings demonstrate how environmental fac-
tors of quality of care and level of skilled care provision
impacted on mortality. Lower regulatory rating of quality
of care was associated with higher hazard ratios com-
pared with top quality rating of care (1 star quality rating
1.15 aHR [1.11–1.20] ref. 5 star quality rating) [21].
Similarly, improved survival was associated with a higher
staff ratio to number of patients [20] and availability of
skilled nurses per bed (e.g. < 4.1 beds per registered
nurse post-acute trauma 0.84 aHR [0.77–0.91] and sur-
gery patients 0.80 aHR [0.75–0.86] ref. > 6.7 beds per
nurse) [19].
Intermediate care units are an important part of the
continuum of services for older people at points of
deterioration in health, or when in transition between
hospital, home or care home. The provision of palliative
care is a commonly cited function of intermediate care
units nationally [10] and internationally, but provision
varies widely depending on service commissioning and if
palliative care is formally recognised in the wider health
system [11]. Sezgin et al.’s systematic review identified
these settings as delivering key elements of an effective
model of care for older people with multimorbidity [8].
Key elements include the presence of a multi-
disciplinary team to provide a single-point of entry for
multiple interventions from self-management of chronic
disease, recovery and rehabilitation, to palliative and end
of life care [8]. Although studies report of patient experi-
ences of palliative care in these settings is better com-
pared to hospital, little information is available about the
provision or contribution of palliative care advice and
support [8]. Our findings show the importance of pallia-
tive with over one in four patients in the last year of life.
The nearness of death is comparable with acute hospi-
tals (28.8%) [38]. Our findings identify triggers for pallia-
tive care assessment including patients with chronic
progressive conditions common in old age, such as
dementia, respiratory and cardiac conditions, and cancer,
high comorbidities (≥ 5 Charlson Index score) and ad-
vanced age. The progressive conditions identified are
often accompanied by serious health-related suffering
likely to benefit from palliative care [1]. However, risk of
end of life was also associated with an ‘acute’ stressor
event such as pneumonia or injury. The high risk of
poor outcome of death for older people with multimor-
bidity and chronic conditions requires the provision of
palliative care alongside treatments supporting recovery.
The global COVID-19 pandemic demonstrated the




0 to 365 days Hazard up to 28 daysa Hazard 29 to 180 daysb Hazard 181 to 365 daysc
n/N (%) n/N (%) Adjusted hazard
ratio (95% CI)
n/N (%) Adjusted hazard
ratio (95% CI)
n/N (%) Adjusted hazard
ratio (95% CI)




3.69 (2.78, 4.91) 274/1315
(21%)







5.01 (3.78, 6.62) 252/1020
(25%)
2.86 (2.45, 3.34) 139/768
(18%)
2.76 (2.26, 3.39)




5.07 (3.80, 6.77) 187/954
(20%)
2.17 (1.82, 2.57) 117/767
(15%)
2.23 (1.80, 2.76)
Acute heart disease (I) 304/955 (32%) 62/955 (6%) 3.38 (2.45, 4.66) 175/893
(20%)
2.13 (1.78, 2.54) 67/718 (9%) 1.32 (1.01, 1.73)
Blood diseases (D) 223/574 (39%) 45/574 (8%) 4.47 (3.13, 6.38) 118/529
(22%)












1.37 (0.89, 2.09) 124/2390
(5%)





3.6 (2.92, 4.43) 4040/25,955
(16%)
2.01 (1.82, 2.22) 2419/21,915
(11%)
1.88 (1.67, 2.12)
Data in bold indicates significant findings. Data are n (%) and represent status at index admission to the intermediate care unit. Adjusted hazard ratio (95% CI).
Main diagnosis on admission (ICD-10 chapter code), full codes Additional File Tables C1 and C4. aHazard of death in the first 28 days of admission. bHazard of
death within 29 to 180 days of admission, which excludes patients that died before 28 days. cHazard of death within 181 to 365 days of admission, which excludes
patients that died before 180 days. Abbreviations: ICD-10 International Classification of Diseases 2010, COPD chronic obstructive pulmonary disease
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vulnerability of older people to acute decline and
death from infection, with highest deaths in older age
groups [39].
Our findings identify priority patient groups likely to
benefit from care orientated towards quality of life and
comprehensive palliative care assessment, and the
requirement for delivery by skilled practitioners to
ensure high-quality care. The inherent uncertain illness
trajectories and wide variation in mortality requires par-
allel planning to support both recovery and plan for and
anticipate end of life. The findings corroborate a model
of care across the care continuum with a range of inte-
grated services including geriatric care with intended
outcomes emphasising function and recovery, and pallia-
tive care with outcomes orientated towards symptoms
and concerns and quality of life [40]. Triggers for care
are advocated as informed by likelihood of benefit and
intended outcomes rather than prognosis when inher-
ently uncertain for this older population group. Using
validated comprehensive outcome measures in routine
care is demonstrated to improve detection of unmet
needs and individual priorities, provision of the right
care at the right time and outcomes of care [41], for
example, using the Integrated Palliative care Outcome
Scale to assess person-centred comprehensive care needs
in routine care [42]. New models of care are indicated
with integration between intermediate care units, geriat-
ric care, hospice care and palliative care, and for a work-
force skilled in geriatric care and palliative care with
access to specialists for patients with complex care
needs. However, there are challenges for intermediate
care facilities. Concerns are reported to ensure levels of
Table 3 Cancer model and factors associated with mortality within 1 year post-admission (complete cases n = 3675)
0 to 365 days Hazard up to 28 daysa Hazard 29 to 365 daysb
Covariate reference
group*
n/N (%) n/N (%) Adjusted hazard ratio (95%
CI)
n/N (%) Adjusted hazard ratio (95%
CI)
Age (years)
18–64 383/743 (52%) 218/743 (29%) 0.95 (0.79, 1.13) 165/525 (31%) 0.67 (0.55, 0.82)
65–74 677/974 (70%) 377/974 (39%) 1.02 (0.88, 1.18) 300/597 (50%) 0.93 (0.79, 1.10)
75–84 903/1194 (76%) 495/1194 (41%) 0.95 (0.83, 1.09) 408/699 (58%) 0.82 (0.71, 0.96)
85–94* 638/764 (84%) 341/764 (45%) 1 297/423 (70%) 1
Sex
Male* 1331/1746 (76%) 763/1746 (44%) 1 568/983 (58%) 1
Female 1270/1929 (66%) 668/1929 (35%) 0.94 (0.84–1.04) 602/1261 (48%) 1.14 (1.01–1.28)
Charlson comorbidity index
0α 0 0 NA 0 NA
1–2* 277/713 (39%) 118/713 (17%) 1 159/595 (27%) 1
3–4 392/665 (59%) 181/665 (27%) 1.35 (1.07, 1.71) 211/484 (44%) 1.23 (1.00, 1.52)
5+ 1932/2297 (84%) 1132/2297 (49%) 2.59 (2.13, 3.15) 800/1165 (69%) 2.09 (1.75, 2.50)
Admission type
Non-Elective* 2095/2418 (87%) 1168/2418 (48%) 1 927/1250 (74%) 1
Elective 506/1257 (40%) 263/1257 (21%) 0.58 (0.50–0.68) 243/994 (24%) 0.42 (0.36–0.50)
Admitted from
Home* 1452/2282 (64%) 831/2282 (36%) 1 621/1451 (43%) 1
Hospital 1121/1359 (82%) 588/1359 (43%) 0.85 (0.77–0.95) 533/771 (69%) 0.86 (0.76–0.98)
Other and unknown 28/34 (82%) 12/34 (35%) 0.95 (0.54–1.68) 16/22 (73%) 1.91 (1.16–3.16)
Cancer site
Breast (C50) 120/534 (22%) 60/534 (11%) 0.34 (0.26, 0.45) 60/474 (13%) 0.23 (0.17, 0.31)
Digestive organs (C15–26) 708/867 (82%) 399/867 (46%) 1.11 (0.98, 1.26) 309/468 (66%) 0.98 (0.85, 1.13)
Lung (C30–32, 34, 37, 38) 458/489 (94%) 265/489 (54%) 1.20 (1.04, 1.39) 193/224 (86%) 1.44 (1.22, 1.70)
Urinary tract (C64–68) 139/314 (44%) 71/314 (23%) 0.7 (0.55, 0.90) 68/243 (28%) 0.6 (0.46, 0.78)
Other 1176/1471 (80%) 636/1471 (43%) 1 540/835 (65%) 1
Data in bold indicates significant findings. Data are n (%) and represent status at index admission to an intermediate care unit. Cancer site (ICD-10 code), full
details Additional File Tables C1 and C4. Adjusted hazard ratio (95% CI). αCharlson index cancer is a weighted factor; hence, zero is not possible in the cancer
model. aHazard of death in the first 28 days of admission. bHazard of death within 29 to 365 days of admission, which excludes patients who died before 28 days.
Definition: home—usual place of residence in the community including personal dwelling and care home (with or without nursing)
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competency in for example palliative care and timely
equitable access to specialist services based on patient
need to support complex clinical decision making on,
for example, managing intractable pain [9–11, 43–45].
Young et al. assert that a key area for development in
intermediate care facilities is investment in training and
support for staff to provide effective care for patients
with multiple and complex needs [44].
Strengths and limitations
A strength of this study is analysis of complete national
datasets linked at the individual level. This enabled
examination of the total population admitted to inter-
mediate care units in England. The use of incident sam-
pling from index admission date and end of life within
1 year gives original detailed understanding on individ-
ual need to inform policy and practice. The findings are
relevant for inpatient settings caring for older people,
such as Skilled Nursing Facilities in the USA and Care
of the Older Person, general medical wards in acute hos-
pitals. Our findings demonstrate individual-level factors
as triggers for palliative and end of life care for older
people in inpatient facilities. This extends understanding
beyond the system-approach reported in prevalence
studies using consensus data [38]. Nevertheless, our
study has limitations. Our systematic review findings
identified the association between mortality and clinical
factors (e.g. functional disability) [13, 15, 16, 18, 22], and
environmental (e.g. skill mix) [18–21] (Additional file D:
Table D2). The use of HSE data impeded wider explor-
ation of associations with clinical variables or intra-
variations and heterogeneity between facilities that are
common [8, 10, 11, 44]. The cancer group formed a
small proportion (4.8%) of the total cohort. Cancer may
be under-reported with inclusion limited to the main
diagnosis of the index admission, as opposed to a history
of cancer. Interpretation of the main diagnosis on the
index admission is treated with caution as some diagnos-
tic groups formed a small proportion of the total cohort,
for example, patients with liver disease.
Conclusion
This national study on patients in the last year of life in
intermediate care units shows that the traditional em-
phasis on rehabilitation and recovery has changed with
an ageing population and the need for greater integra-
tion of palliative care. Adults admitted to these facilities
are mainly older with multiple care needs associated
with chronic progressive conditions and inherent uncer-
tain illness trajectories of recovery or continued decline.
Over one in four patients admitted died within 1 year.
Those living with chronic progressive conditions, cancer
and multimorbidity had increased risk of end of life. Pal-
liative care must be integrated as part of comprehensive
care in intermediate care facilities that encompasses the
paramount importance of quality of life for an increas-
ingly older population. Our findings are relevant for
acute inpatient hospital facilities caring for older people
to align care with the needs of ageing populations. Fu-
ture research should evaluate new models of care for
intermediate care facilities that integrate geriatric care
and palliative care across the continuum of care and into
end of life, with attention to economic evaluation of in-
vestment in workforce training and skill mix to deliver
high-quality care.
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